Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01470742 | Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT02451956 | Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy | completed | Phase 2 | 21 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 |
| clinicaltrials |
| NCT02593591 | Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic. | completed | — | 40 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT02691780 | Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors | withdrawn | N/A | 0 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT03086291 | A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy | unknown | Phase 1 | 9 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT03147404 | Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic (GEP) Neuroendocrine Carcinoma (NEC, WHO Grade 3) as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes(MS100070-0177) | completed | Phase 2 | 14 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT04202328 | T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer | unknown | — | 1,000 | Samsung Medical CenterOTHER | 1 | Dec 19, 2019 | clinicaltrials |
| NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | completed | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT02520453 | Adjuvant Durvalumab for Esophageal Cancer | unknown | Phase 2 | 86 | Samsung Medical CenterOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT03656094 | Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors | unknown | Phase 2 | 98 | Samsung Medical CenterOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT02290574 | Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial(NEOTREAT) | terminated | N/A | 14 | Samsung Medical CenterOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT04116827 | Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device | unknown | — | 20 | Samsung Medical CenterOTHER | 1 | Oct 7, 2019 | clinicaltrials |
| NCT03479099 | Liquid Biopsy in Lung Cancer | completed | — | 111 | Samsung Medical CenterOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT04048395 | Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea(FLPOD24) | unknown | — | 80 | Samsung Medical CenterOTHER | 1 | Aug 7, 2019 | clinicaltrials |
| NCT02212496 | Identification the Cause of Cerebral Infarction in Patients With Cancer | completed | — | 118 | Samsung Medical CenterOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01092481 | Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy | unknown | Phase 3 | 1,580 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01470443 | Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma | unknown | Phase 3 | 240 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01498757 | Genome-wide Association Study | withdrawn | — | 0 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01472601 | A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile | unknown | — | 2,660 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT02067754 | Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer | completed | — | 396 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT02350686 | XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy | unknown | Phase 2 | 67 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT02848066 | Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker | completed | — | 353 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03061708 | Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy(AZD2014) | terminated | Phase 2 | 1 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03082833 | Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy | terminated | Phase 2 | 1 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03083210 | Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET | unknown | Phase 4 | 28 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03166176 | Phase II Trial of Vistusertib(AZD2014) Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy(TSC1/2_SC) | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03166904 | Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy(RICTOR_SC) | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT02934984 | Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer | unknown | — | 100 | Samsung Medical CenterOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02592746 | A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC | unknown | Phase 2 | 182 | Samsung Medical CenterOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT03881878 | TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery | unknown | Phase 1 / Phase 2 | 67 | Samsung Medical CenterOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT01007526 | Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma(CCRT-VIDL) | completed | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT03366675 | AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3] | terminated | Phase 2 | 15 | Samsung Medical CenterOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03744273 | Capsule Biopsy in Acellular Dermal Matrix-based Prosthetic Breast Reconstruction: a Prospective Pilot Study | completed | N/A | — | Samsung Medical CenterOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT01965119 | Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma(JAK2) | completed | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT03231462 | Impact of Perioperative Physical Activity on Postoperative Pulmonary Complications and Quality of Life Among Esophageal Cancer Patients | unknown | — | 180 | Samsung Medical CenterOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT02688907 | Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation | terminated | Phase 2 | 7 | Samsung Medical CenterOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT03106155 | Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification([SUKSES-D]) | terminated | Phase 2 | 4 | Samsung Medical CenterOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT03628131 | Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 46 | Samsung Medical CenterOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT00793845 | Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma | completed | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT01807468 | Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors | unknown | Phase 2 | 12 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | unknown | Phase 2 | 41 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02787876 | Pegteograstim in Children With Solid Tumors | unknown | Phase 2 | 34 | Samsung Medical CenterOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02280785 | Brentuximab Vedotin for Relapsed/Refractory CD30-positive Non-Hodgkin Lymphomas(BRAN) | completed | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT02424045 | Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma | completed | Phase 2 | 30 | Samsung Medical CenterOTHER | 0 | Sep 6, 2018 | clinicaltrials |
| NCT02605629 | EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors(VOLUME) | completed | N/A | 32 | Samsung Medical CenterOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT02986412 | A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)(VOLUME2) | completed | N/A | 19 | Samsung Medical CenterOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03397745 | Bispectral Index Throughout Esophageal Cancer Operation | completed | N/A | 44 | Samsung Medical CenterOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT03616691 | Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC | unknown | Phase 2 | 46 | Samsung Medical CenterOTHER | 0 | Aug 6, 2018 | clinicaltrials |
| NCT03098108 | Concurrent Chemo-proton Radiotherapy With or Without Resection and Spacer Insertion for Loco-regional Recurrence of Previous Irradiated Rectal Cancer(RECCPT) | unknown | N/A | 24 | Samsung Medical CenterOTHER | 1 | Jun 28, 2018 | clinicaltrials |
| NCT03570281 | Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)(ENCHASE) | unknown | Phase 2 / Phase 3 | 40 | Samsung Medical CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials